Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases

By Rick Archer (August 27, 2021, 1:42 PM EDT) -- Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.

A New York bankruptcy judge postponed confirmation of Purdue's Chapter 11 plan until Wednesday. (AP Photo/Douglas Healey, File) At a virtual hearing, U.S. Bankruptcy Court Judge Robert Drain said he was delaying his decision on the confirmation of Purdue's Chapter 11 plan until Wednesday, turning what had been scheduled as the time...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!